Factors influencing primary care physicians’ decision to order prostate-specific antigen (PSA) test for men without prostate cancer

Author： Hayat Roshanai Afsaneh   Nordin Karin   Berglund Gunilla  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.52, Iss.8, 2013-11, pp. : 1602-1608

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical Evaluation of Free PSA/Total PSA (Prostate-specific Antigen) Ratio in the Diagnosis of Prostate Cancer

By Filella X.   Alcover J.   Molina R.   Rodriguez A.   Carretero P.   Ballesta A.M.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1226-1229

Elsevier

Access to resources Recommend Favorite

Factors associated with blood loss during radical prostatectomy for localized prostate cancer in the prostate-specific antigen (PSA)-era: an overview of the department of defense (DOD) Center for Prostate Disease Research (CPDR) national database

By Moul J.W.   Sun L.   Wu H.   McLeod D.G.   Amling C.   Lance R.   Foley J.   Sexton W.   Kusuda L.   Chung A.   Soderdahl D.   Donahue T.  

Urologic Oncology: Seminars and Original Investigations, Vol. 21, Iss. 6, 2003-11 ,pp. : 447-455

Elsevier

Access to resources Recommend Favorite

Value of PSA (Prostate-specific Antigen) in the Detection of Prostate Cancer in Patients with Urological Symptoms. Results of a Multicentre Study

By Cooperative Group for the Diagnosis of Prostate Cancer   Filella X.   Molina R.   Ballesta A.M.   Gil M.J.   Allepuz C.   Rioja L.A.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1125-1128

Elsevier

Access to resources Recommend Favorite

Nadir prostate-specific antigen (PSA) level and time to PSA nadir following primary androgen deprivation therapy as independent prognostic factors in a Japanese large-scale prospective cohort study (J-CaP)

By Kitagawa Yasuhide   Ueno Satoru   Izumi Kouji   Mizokami Atsushi   Hinotsu Shiro   Akaza Hideyuki   Namiki Mikio  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 4, 2014-04 ,pp. : 673-679

Springer Publishing Company

Access to resources Recommend Favorite

The free/total prostate-specific antigen ratio (%fPSA) is the best predictor of tumor involvement in the radical prostatectomy specimen among men with an elevated PSA

By Grossklaus D.J.   Smith J.A.   Shappell S.B.   Coffey C.S.   Chang S.S.   Cookson M.S.  

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 5, 2002-09 ,pp. : 195-198

Elsevier

Access to resources Recommend Favorite